The 26th Congress of the European Hematology Association (EHA) 2021, 9-17 June, will see leading experts from around the globe gather virtually for a fantastic demonstration of the most ground-breaking research in the field of hematology.

Exciting data on promising biomarkers, CAR T-cell and NK-cell therapy, transplant research, novel drugs and more will be showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, thalessemia, and beyond.

View all videos

EHA 2021

The 26th Congress of the European Hematology Association (EHA) 2021
09–17 June 2021 | Virtual Meeting

Preparing to leave bright and early tomorrow for #ASH22. Virtual access gained (v important to get good screenshots). Tweeting fingers at the ready!

Hope to see many of you there in person - do come and say hi.

Peter Borchmann (@UKKoeln) shares some insights into the HD21 trial & the safety profile of the BrECADD regimen:

🎥: http://ow.ly/FB4V50LXCNc

#ISHL12 #HemOnc #Hodgkin #LymSM #ImmunoOnc

Heading to #ASH22 & want to make the most of Twitter? Check out @doctorpemm's tips on creating the 'perfect' Tweet📱

@doctorpemm, @mpdrc & @harrisoncn1 discuss how to create Tweets that enhance understanding & lead to debate and discussion💡

👉 https://lnkd.in/et-UTsbj

Load More...

EHA 2021

The 26th Congress of the European Hematology Association (EHA) 2021
09–17 June 2021 | Virtual Meeting

The 26th Congress of the European Hematology Association (EHA) 2021, 9-17 June, will see leading experts from around the globe gather virtually for a fantastic demonstration of the most ground-breaking research in the field of hematology.

Exciting data on promising biomarkers, CAR T-cell and NK-cell therapy, transplant research, novel drugs and more will be showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, thalessemia, and beyond.

View all videos

Preparing to leave bright and early tomorrow for #ASH22. Virtual access gained (v important to get good screenshots). Tweeting fingers at the ready!

Hope to see many of you there in person - do come and say hi.

Peter Borchmann (@UKKoeln) shares some insights into the HD21 trial & the safety profile of the BrECADD regimen:

🎥: http://ow.ly/FB4V50LXCNc

#ISHL12 #HemOnc #Hodgkin #LymSM #ImmunoOnc

Heading to #ASH22 & want to make the most of Twitter? Check out @doctorpemm's tips on creating the 'perfect' Tweet📱

@doctorpemm, @mpdrc & @harrisoncn1 discuss how to create Tweets that enhance understanding & lead to debate and discussion💡

👉 https://lnkd.in/et-UTsbj

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter